Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > EBITDA Margin

Arcus Biosciences Inc EBITDA Margin Chart (RCUS)

Arcus Biosciences Inc annual/quarterly EBITDA Margin from 2018 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Arcus Biosciences Inc EBITDA Margin for the quarter ending September 09, 2018 was $-260m
Other Margins & Efficiency Metrics:
  • Arcus Biosciences Inc Return on Capital % for the quarter ending December 12, 2018 was -14.04
  • Arcus Biosciences Inc Return on Equity % for the quarter ending December 12, 2018 was -20.49
View Chart On Koyfin

Quarterly RCUS EBITDA Margin Data

09/2018$-260m